Detalhe da pesquisa
1.
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Nature
; 628(8007): 442-449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538798
2.
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Nature
; 629(8012): E12, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684813
3.
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
N Engl J Med
; 384(7): 630-642, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596357
4.
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Am J Obstet Gynecol
; 230(2): 237.e1-237.e11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863160
5.
"In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.
BMC Womens Health
; 24(1): 233, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610011
6.
Uterine Fibroids: Hiding in Plain Sight.
Physiology (Bethesda)
; 37(1): 16-27, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34964688
7.
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
Lancet
; 400(10356): 896-907, 2022 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116480
8.
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
N Engl J Med
; 382(4): 328-340, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971678
9.
Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Am J Obstet Gynecol
; 228(3): 320.e1-320.e11, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370871
10.
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
Am J Obstet Gynecol
; 229(3): 275.e1-275.e17, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244458
11.
New treatment options for nonsurgical management of uterine fibroids.
Curr Opin Obstet Gynecol
; 35(4): 288-293, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144584
12.
Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
J Minim Invasive Gynecol
; 30(10): 813-819, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286130
13.
Fertility trends and comparisons in a historical cohort of US women with primary infertility.
Reprod Health
; 19(1): 13, 2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042514
14.
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma.
Cancer Immunol Immunother
; 70(3): 721-732, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915319
15.
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Am J Obstet Gynecol
; 224(1): 72.e1-72.e50, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702363
16.
Non-extirpative Treatments for Uterine Myomas: Measuring Success.
J Minim Invasive Gynecol
; 28(3): 442-452.e4, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841756
17.
Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Am J Obstet Gynecol
; 222(4): 345.e1-345.e22, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678093
18.
Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging.
Physiology (Bethesda)
; 33(6): 374-383, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303778
19.
Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Am J Obstet Gynecol
; 220(2): 179.e1-179.e10, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447212
20.
FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.
Am J Obstet Gynecol
; 220(2): 174.e1-174.e13, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696556